Tegaserod has a favorable safety & tolerability profile in patients with constipation predominant and alternating forms of irritable bowel syndrome (IBS)

✍ Scribed by Peter J. Whorwell; Steven Krumholz; Stefan Mueller Lissner; Colleen Schmitt; Cornelia Dunger-Baldauf; Peter C. Rueegg

• Book ID: 119424801
• Publisher: Elsevier Science
• Year: 2000
• Tongue: English
• Weight: 173 KB
• Volume: 118
• Category: Article
• ISSN: 0016-5085
• DOI: 10.1016/s0016-5085(00)80649-6